Jason Bacharach, OD
Ophthalmology · Petaluma
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 42 years
- Hahneman Medical College of the Pacific, 1984
Offices
1 location · North Bay Eye Associates, A Medical Corporation · 11 clinicians in this group
Hospitals listed: Petaluma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bacharach’s office at (707) 762-3573 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G73984 · Current
Licensed to practise in California · since 1992 · expires 2028-05-31 · Hahnemann University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$589,803
Medicare paid this office $589,803 for 1,909 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 1,227 | $150,356 | $70 |
| Established patient complete exam of visual system | 773 | $77,470 | $97 |
| Removal of cataract with insertion of prosthetic lens | 121 | $71,581 | $353 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 16 | $32,418 | None |
| Exam of visual field with extended testing | 550 | $29,429 | $51 |
See all 25 services
| Established patient problem focused exam of visual system | 1,227 | $150,356 | $70 |
| Established patient complete exam of visual system | 773 | $77,470 | $97 |
| Removal of cataract with insertion of prosthetic lens | 121 | $71,581 | $353 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 16 | $32,418 | None |
| Exam of visual field with extended testing | 550 | $29,429 | $51 |
| Incision to improve eye fluid flow | 25 | $27,210 | $735 |
| Imaging of optic nerve | 743 | $22,267 | $29 |
| Laser repair to improve eye fluid flow | 66 | $19,158 | $198 |
| Return visit (30+ min) | 173 | $18,956 | $105 |
| Complex removal of cataract with insertion of prosthetic lens | 19 | $16,017 | $552 |
| Removal of recurring cataract in lens capsule using a laser | 45 | $15,539 | $283 |
| Dilation of fluid outflow drainage within eye | 18 | $15,370 | $530 |
| Imaging of retina | 419 | $14,999 | $34 |
| Short return visit (20+ min) | 160 | $12,656 | $70 |
| New patient complete exam of visual system | 111 | $12,436 | $112 |
| Exam of the internal drainage system of eye | 304 | $6,625 | $21 |
| Measurement of corneal curvature and depth of eye | 141 | $6,611 | $31 |
| New patient visit (45+ min) | 43 | $5,105 | $119 |
| Short return visit | 77 | $3,949 | $46 |
| Injection of medication into eye | 17 | $2,864 | $136 |
| New patient visit (30+ min) | 20 | $1,499 | $75 |
| Microfluid analysis of tears | 31 | $1,410 | $22 |
| Photography of the retina | 44 | $1,273 | $29 |
| Ultrasound scan of cornea to determine thickness | 92 | $821 | $9 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $700 | $44 |
Procedures Medicare counted
| Cataract surgery | 298 | More than 89% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 214 | 174 | 186 | 181 | 160 | 203 |
| Laser repair to improve eye fluid flow | 96 | 102 | 90 | 59 | 107 | 97 |
| Removal of recurring cataract in lens capsule using a laser | 64 | 72 | 74 | 68 | 73 | 55 |
| Complex removal of cataract with insertion of prosthetic lens | 23 | 35 | 20 | 27 | 23 | 29 |
| Incision to improve eye fluid flow | 27 | 38 | 20 | 22 | – | 37 |
| Dilation of fluid outflow drainage within eye | – | – | 21 | 33 | 36 | 29 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,909 Original Medicare patients in 2024. Average age 78 · Under 65 1% · 85 and older 20% · Women 63% · Also on Medicaid 7% · Health risk score 1.02. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 65% · Coronary heart disease 24% · Diabetes 19% · Chronic kidney disease 17% · Atrial fibrillation 17% · Cancer 15% · Depression 15% · Heart failure 11% · COPD 11% · Stroke 6% · Dementia 4%.
The office billed $2,076,852, Medicare allowed $809,380 and paid $589,803; for 6,858 services of 61 kinds; $32,488 of it was for drugs given in the office and $557,315 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,909 | 6,858 | 78 | 1.02 | $2,076,852 | $589,803 |
| 2023 | 1,948 | 7,038 | 78 | 0.98 | $2,101,074 | $625,556 |
| 2022 | 2,003 | 7,438 | 78 | 0.99 | $2,067,488 | $622,179 |
| 2021 | 1,969 | 8,128 | 78 | 1.02 | $2,208,984 | $684,964 |
| 2020 | 1,875 | 6,994 | 78 | 1.03 | $1,986,761 | $571,847 |
| 2019 | 2,223 | 8,846 | 77 | 1.09 | $1,745,246 | $693,723 |
| 2018 | 2,247 | 8,729 | 77 | 1.10 | $1,828,834 | $645,505 |
| 2017 | 2,249 | 8,612 | 77 | 1.09 | $1,753,726 | $654,730 |
| 2016 | 2,316 | 9,047 | 77 | 1.06 | $1,960,937 | $728,587 |
| 2015 | 2,286 | 8,561 | 77 | 1.08 | $1,649,939 | $655,564 |
| 2014 | 2,196 | 8,128 | 77 | 1.05 | $1,695,129 | $669,270 |
| 2013 | 2,313 | 8,725 | 77 | 1.06 | $1,756,038 | $701,046 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Established patient problem focused exam of visual system | 1,255 | $155,910 | $72 |
| Established patient complete exam of visual system | 712 | $72,239 | $99 |
| Removal of cataract with insertion of prosthetic lens | 96 | $56,009 | $350 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 20 | $50,126 | None |
| Exam of visual field with extended testing | 633 | $34,019 | $51 |
| Laser repair to improve eye fluid flow | 76 | $22,269 | $208 |
| Return visit (30+ min) | 208 | $21,792 | $99 |
| Imaging of optic nerve | 685 | $21,140 | $30 |
| Removal of recurring cataract in lens capsule using a laser | 67 | $20,803 | $285 |
| Dilation of fluid outflow drainage within eye | 25 | $18,926 | $526 |
| New patient complete exam of visual system | 147 | $17,012 | $116 |
| Short return visit (20+ min) | 210 | $16,630 | $71 |
| Complex removal of cataract with insertion of prosthetic lens | 17 | $13,722 | $597 |
| Imaging of retina | 353 | $12,553 | $33 |
| Revision or repair of operative wound of eye | 11 | $8,008 | $667 |
| New patient visit (45+ min) | 60 | $7,783 | $130 |
| Exam of the internal drainage system of eye | 307 | $6,943 | $22 |
| Measurement of corneal curvature and depth of eye | 125 | $6,004 | $34 |
| Destruction of lens tissue using laser | 15 | $5,952 | $313 |
| Short return visit | 95 | $5,360 | $48 |
| Injection of medication into eye | 20 | $4,960 | $160 |
| New patient visit (30+ min) | 28 | $2,187 | $78 |
| Photography of the retina | 47 | $1,433 | $30 |
| Ultrasound scan of cornea to determine thickness | 119 | $1,088 | $9 |
| Fitting of contact lens for treatment of eye surface disease | 14 | $451 | $32 |
| Injection, fluorouracil, 500 mg | 11 | $21 | None |
2022: 28 services
| Established patient problem focused exam of visual system | 1,204 | $147,876 | $70 |
| Established patient complete exam of visual system | 845 | $83,877 | $96 |
| Removal of cataract with insertion of prosthetic lens | 107 | $65,044 | $359 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 15 | $39,010 | None |
| Exam of visual field with extended testing | 718 | $38,485 | $50 |
| Short return visit (20+ min) | 337 | $28,632 | $68 |
| Imaging of optic nerve | 733 | $22,683 | $30 |
| Dilation of fluid outflow drainage within eye | 22 | $22,454 | $680 |
| Removal of recurring cataract in lens capsule using a laser | 55 | $18,945 | $279 |
| New patient complete exam of visual system | 150 | $17,201 | $115 |
| Incision to improve eye fluid flow | 16 | $16,536 | $752 |
| Complex removal of cataract with insertion of prosthetic lens | 22 | $15,306 | $567 |
| Return visit (30+ min) | 139 | $14,538 | $100 |
| Laser repair to improve eye fluid flow | 42 | $12,230 | $207 |
| Imaging of retina | 325 | $11,096 | $32 |
| Exam of the internal drainage system of eye | 366 | $8,010 | $22 |
| Measurement of corneal curvature and depth of eye | 135 | $6,831 | $35 |
| Short return visit | 103 | $4,992 | $43 |
| New patient visit (45+ min) | 45 | $4,861 | $108 |
| Injection of medication into eye | 15 | $3,605 | $150 |
| New patient visit (30+ min) | 39 | $3,459 | $89 |
| Photography of the retina | 73 | $2,090 | $29 |
| Ultrasound scan of cornea to determine thickness | 137 | $1,228 | $9 |
| Telephone medical discussion with physician, 5-10 minutes | 28 | $1,099 | $32 |
| New patient problem focused exam of visual system | 16 | $1,025 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $573 | $52 |
| Extended exam of the back part of the eye with retinal drawing | 16 | $340 | $20 |
| Imaging of front third of eye | 11 | $299 | $23 |
2021: 31 services
| Established patient problem focused exam of visual system | 1,264 | $176,191 | $72 |
| Established patient complete exam of visual system | 940 | $95,423 | $98 |
| Removal of cataract with insertion of prosthetic lens | 102 | $62,330 | $335 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 17 | $53,196 | None |
| Exam of visual field with extended testing | 770 | $42,894 | $53 |
| Short return visit (20+ min) | 325 | $29,413 | $72 |
| Imaging of optic nerve | 792 | $24,381 | $30 |
| Removal of recurring cataract in lens capsule using a laser | 56 | $20,859 | $282 |
| Laser repair to improve eye fluid flow | 57 | $19,164 | $213 |
| New patient complete exam of visual system | 153 | $18,839 | $123 |
| Dilation of fluid outflow drainage within eye | 15 | $17,473 | $832 |
| Incision to improve eye fluid flow | 15 | $14,760 | $738 |
| Imaging of retina | 385 | $13,538 | $33 |
| Insertion of eye fluid drainage device | 11 | $10,690 | $891 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $9,587 | $479 |
| Revision or repair of operative wound of eye | 11 | $8,439 | $703 |
| Exam of the internal drainage system of eye | 343 | $7,994 | $23 |
| Short return visit | 140 | $7,778 | $45 |
| Measurement of corneal curvature and depth of eye | 115 | $6,604 | $40 |
| Injection of medication into eye | 17 | $5,121 | $160 |
| Photography of the retina | 111 | $3,667 | $33 |
| New patient visit (30+ min) | 35 | $2,895 | $83 |
| Microfluid analysis of tears | 48 | $2,360 | $22 |
| New patient problem focused exam of visual system | 20 | $1,212 | $61 |
| Ultrasound scan of cornea to determine thickness | 116 | $1,136 | $10 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $933 | $29 |
| Imaging of front third of eye | 22 | $631 | $29 |
| Removal of eyelashes using forceps | 15 | $552 | $20 |
| Extended exam of the back part of the eye with retinal drawing | 14 | $287 | $19 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 18 | $161 | $8 |
| Injection, fluorouracil, 500 mg | 11 | $14 | None |
2020: 31 services
| Established patient problem focused exam of visual system | 1,174 | $131,666 | $66 |
| Established patient complete exam of visual system | 913 | $90,188 | $94 |
| Removal of cataract with insertion of prosthetic lens | 97 | $55,640 | $320 |
| Exam of visual field with extended testing | 636 | $33,972 | $49 |
| Incision to improve eye fluid flow | 28 | $24,822 | $653 |
| Short return visit (20+ min) | 295 | $20,148 | $57 |
| Removal of recurring cataract in lens capsule using a laser | 56 | $19,810 | $275 |
| Imaging of optic nerve | 647 | $19,403 | $29 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $18,044 | $516 |
| Insertion of eye fluid drainage device | 15 | $16,283 | $905 |
| Laser repair to improve eye fluid flow | 50 | $14,660 | $201 |
| Revision or repair of operative wound of eye | 18 | $13,179 | $659 |
| Imaging of retina | 297 | $10,505 | $33 |
| New patient complete exam of visual system | 100 | $10,256 | $103 |
| Exam of the internal drainage system of eye | 368 | $8,085 | $22 |
| Measurement of corneal curvature and depth of eye | 114 | $6,504 | $40 |
| Laser repair to improve eye fluid flow | 21 | $5,263 | $181 |
| Short return visit | 115 | $4,368 | $32 |
| New patient visit (30+ min) | 46 | $4,102 | $89 |
| Photography of the retina | 113 | $4,072 | $36 |
| Microfluid analysis of tears | 53 | $2,501 | $22 |
| New patient problem focused exam of visual system | 23 | $1,495 | $65 |
| Ultrasound scan of cornea to determine thickness | 134 | $1,291 | $10 |
| New patient visit (15+ min) | 17 | $987 | $58 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 31 | $789 | $21 |
| Telephone medical discussion with physician, 5-10 minutes | 31 | $677 | $22 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $540 | $42 |
| Imaging of front third of eye | 20 | $507 | $25 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 33 | $401 | $11 |
| Extended exam of the back part of the eye with retinal drawing | 15 | $311 | $21 |
| Injection, fluorouracil, 500 mg | 17 | $24 | None |
2019: 27 services
| Established patient problem focused exam of visual system | 1,532 | $185,895 | $67 |
| Established patient complete exam of visual system | 1,078 | $109,330 | $96 |
| Removal of cataract with insertion of prosthetic lens | 117 | $86,727 | $405 |
| Exam of visual field with extended testing | 893 | $48,686 | $50 |
| Short return visit (20+ min) | 416 | $28,301 | $55 |
| Revision or repair of operative wound of eye | 31 | $24,159 | $604 |
| Imaging of optic nerve | 774 | $23,540 | $30 |
| New patient complete exam of visual system | 188 | $20,599 | $110 |
| Insertion of eye fluid drainage device | 20 | $18,234 | $829 |
| Incision to improve eye fluid flow | 18 | $17,856 | $661 |
| Removal of recurring cataract in lens capsule using a laser | 56 | $17,318 | $271 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $14,723 | $640 |
| Laser repair to improve eye fluid flow | 44 | $12,959 | $209 |
| Imaging of retina | 352 | $12,736 | $33 |
| Exam of the internal drainage system of eye | 471 | $9,974 | $21 |
| Measurement of corneal curvature and depth of eye | 144 | $9,166 | $43 |
| Destruction of lens tissue using laser | 18 | $6,519 | $310 |
| Photography of the retina | 158 | $6,324 | $40 |
| Laser repair to improve eye fluid flow | 28 | $6,003 | $177 |
| Short return visit | 83 | $3,340 | $34 |
| Ultrasound scan of cornea to determine thickness | 255 | $2,567 | $10 |
| Microfluid analysis of tears | 50 | $2,511 | $22 |
| Closure of tear duct opening using plug | 11 | $2,056 | $171 |
| New patient problem focused exam of visual system | 26 | $1,622 | $62 |
| New patient visit (30+ min) | 17 | $1,329 | $78 |
| Imaging of front third of eye | 17 | $371 | $22 |
| Injection, fluorouracil, 500 mg | 28 | $45 | None |
2018: 29 services
| Established patient problem focused exam of visual system | 1,507 | $164,977 | $63 |
| Removal of cataract with insertion of prosthetic lens | 145 | $105,488 | $425 |
| Established patient complete exam of visual system | 1,124 | $101,568 | $86 |
| Exam of visual field with extended testing | 855 | $44,635 | $47 |
| Short return visit (20+ min) | 414 | $26,127 | $50 |
| Imaging of optic nerve | 803 | $23,247 | $28 |
| Removal of recurring cataract in lens capsule using a laser | 64 | $23,042 | $256 |
| New patient complete exam of visual system | 182 | $18,558 | $102 |
| Complex removal of cataract with insertion of prosthetic lens | 23 | $16,136 | $461 |
| Revision or repair of operative wound of eye | 21 | $14,905 | $596 |
| Imaging of retina | 337 | $11,540 | $31 |
| Measurement of corneal curvature and depth of eye | 159 | $10,252 | $46 |
| Exam of the internal drainage system of eye | 496 | $9,489 | $19 |
| Destruction of lens tissue using laser | 23 | $8,468 | $314 |
| Laser repair to improve eye fluid flow | 33 | $7,485 | $187 |
| Photography of the retina | 156 | $6,786 | $43 |
| Laser repair to improve eye fluid flow | 29 | $5,774 | $170 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $5,455 | $195 |
| Internal insertion of eye fluid drainage device | 21 | $5,172 | $167 |
| Short return visit | 75 | $2,774 | $32 |
| Ultrasound scan of cornea to determine thickness | 203 | $2,403 | $12 |
| Microfluid analysis of tears | 39 | $1,718 | $22 |
| New patient problem focused exam of visual system | 23 | $1,144 | $50 |
| New patient visit (30+ min) | 16 | $992 | $62 |
| Removal of eyelashes using forceps | 11 | $899 | $39 |
| Removal of foreign body from external eye (conjunctiva or sclera) | 11 | $620 | $56 |
| Imaging of front third of eye | 14 | $365 | $24 |
| Examination of eye by ophthalmoscope with retinal drawing | 16 | $335 | $20 |
| Injection, fluorouracil, 500 mg | 18 | $29 | None |
2017: 26 services
| Established patient problem focused exam of visual system | 1,521 | $170,433 | $61 |
| Removal of cataract with insertion of prosthetic lens | 138 | $102,680 | $433 |
| Established patient complete exam of visual system | 1,053 | $101,833 | $91 |
| Exam of visual field with extended testing | 792 | $40,827 | $48 |
| Short return visit (20+ min) | 479 | $28,153 | $50 |
| Removal of recurring cataract in lens capsule using a laser | 74 | $23,577 | $251 |
| New patient complete exam of visual system | 212 | $21,527 | $102 |
| Imaging of optic nerve | 755 | $21,422 | $28 |
| Internal insertion of eye fluid drainage device | 25 | $19,734 | $519 |
| Insertion of eye fluid drainage device | 14 | $11,984 | $856 |
| Exam of the internal drainage system of eye | 581 | $11,934 | $20 |
| Measurement of corneal curvature and depth of eye | 162 | $11,497 | $51 |
| Laser repair to improve eye fluid flow | 45 | $10,992 | $183 |
| Imaging of retina | 293 | $9,732 | $31 |
| Revision or repair of operative wound of eye | 11 | $7,814 | $601 |
| Destruction of lens tissue using laser | 19 | $6,938 | $315 |
| Photography of the retina | 94 | $5,131 | $53 |
| Laser repair to improve eye fluid flow | 19 | $4,201 | $162 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 14 | $4,122 | $187 |
| Microfluid analysis of tears | 59 | $3,021 | $22 |
| Short return visit | 56 | $2,073 | $33 |
| Removal of eyelashes using forceps | 17 | $1,524 | $44 |
| Ultrasound scan of cornea to determine thickness | 130 | $1,506 | $12 |
| New patient problem focused exam of visual system | 19 | $1,130 | $59 |
| Examination of eye by ophthalmoscope with retinal drawing | 27 | $572 | $21 |
| Imaging of front third of eye | 18 | $443 | $25 |
2016: 27 services
| Established patient problem focused exam of visual system | 1,402 | $151,574 | $63 |
| Removal of cataract with insertion of prosthetic lens | 167 | $129,400 | $442 |
| Established patient complete exam of visual system | 896 | $84,255 | $90 |
| Short return visit (20+ min) | 915 | $67,044 | $51 |
| Exam of visual field with extended testing | 780 | $41,814 | $49 |
| Internal insertion of eye fluid drainage device | 34 | $41,296 | $810 |
| New patient complete exam of visual system | 286 | $30,478 | $107 |
| Removal of recurring cataract in lens capsule using a laser | 76 | $24,421 | $254 |
| Imaging of optic nerve | 664 | $22,777 | $33 |
| Measurement of corneal curvature and depth of eye | 181 | $13,602 | $51 |
| Exam of the internal drainage system of eye | 634 | $12,891 | $20 |
| Insertion of eye fluid drainage device | 13 | $12,819 | $855 |
| Imaging of retina | 279 | $10,461 | $34 |
| Laser repair to improve eye fluid flow | 36 | $10,262 | $228 |
| Laser repair to improve eye fluid flow | 40 | $9,628 | $201 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $9,179 | $656 |
| Photography of the retina | 114 | $6,039 | $53 |
| Destruction of lens tissue using laser | 15 | $5,572 | $310 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $4,705 | $196 |
| Short return visit | 76 | $2,822 | $31 |
| Microfluid analysis of tears | 45 | $2,051 | $22 |
| Removal of eyelashes using forceps | 23 | $2,011 | $47 |
| Ultrasound scan of cornea to determine thickness | 164 | $1,935 | $12 |
| New patient problem focused exam of visual system | 24 | $1,504 | $63 |
| Simple or single drainage of skin abscess | 11 | $992 | $76 |
| Imaging of front third of eye | 33 | $886 | $27 |
| Examination of eye by ophthalmoscope with retinal drawing | 36 | $756 | $20 |
2015: 25 services
| Established patient problem focused exam of visual system | 1,335 | $144,460 | $62 |
| Removal of cataract with insertion of prosthetic lens | 123 | $94,290 | $419 |
| Established patient complete exam of visual system | 861 | $81,971 | $92 |
| Short return visit (20+ min) | 948 | $76,214 | $56 |
| Exam of visual field with extended testing | 761 | $39,679 | $49 |
| New patient complete exam of visual system | 218 | $23,217 | $106 |
| Imaging of optic nerve | 652 | $22,335 | $33 |
| Insertion of eye fluid drainage device | 19 | $17,913 | $853 |
| Removal of recurring cataract in lens capsule using a laser | 57 | $17,632 | $259 |
| Internal insertion of eye fluid drainage device | 19 | $17,006 | $810 |
| Complex removal of cataract with insertion of prosthetic lens | 16 | $13,541 | $564 |
| Exam of the internal drainage system of eye | 599 | $12,489 | $20 |
| Measurement of corneal curvature and depth of eye | 157 | $11,431 | $51 |
| Photography of the retina | 170 | $11,241 | $66 |
| Laser repair to improve eye fluid flow | 33 | $10,730 | $275 |
| Imaging of retina | 209 | $7,726 | $35 |
| Revision or repair of operative wound of eye | 11 | $6,749 | $614 |
| Laser repair to improve eye fluid flow | 18 | $5,913 | $246 |
| Short return visit | 95 | $3,841 | $35 |
| New patient problem focused exam of visual system | 57 | $3,248 | $57 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 11 | $2,936 | $196 |
| Microfluid analysis of tears | 37 | $1,674 | $21 |
| Removal of eyelashes using forceps | 18 | $1,617 | $43 |
| Ultrasound scan of cornea to determine thickness | 133 | $1,550 | $12 |
| Examination of eye by ophthalmoscope with retinal drawing | 37 | $762 | $20 |
2014: 24 services
| Established patient problem focused exam of visual system | 1,374 | $169,324 | $64 |
| Removal of cataract with insertion of prosthetic lens | 131 | $102,554 | $448 |
| Established patient complete exam of visual system | 775 | $74,810 | $93 |
| Short return visit (20+ min) | 782 | $61,358 | $56 |
| Exam of visual field with extended testing | 660 | $35,390 | $50 |
| Internal insertion of eye fluid drainage device | 21 | $26,641 | $807 |
| Complex removal of cataract with insertion of prosthetic lens | 33 | $25,749 | $585 |
| Imaging of optic nerve | 673 | $24,415 | $34 |
| New patient complete exam of visual system | 196 | $21,905 | $112 |
| Insertion of eye fluid drainage device | 21 | $20,119 | $875 |
| Removal of recurring cataract in lens capsule using a laser | 45 | $14,222 | $263 |
| Measurement of corneal curvature and depth of eye | 162 | $11,243 | $49 |
| Exam of the internal drainage system of eye | 502 | $10,755 | $21 |
| Laser repair to improve eye fluid flow | 27 | $9,661 | $284 |
| Revision or repair of operative wound of eye | 13 | $8,250 | $635 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 18 | $5,773 | $199 |
| Imaging of retina | 160 | $5,653 | $35 |
| Short return visit | 118 | $4,299 | $33 |
| Laser repair to improve eye fluid flow | 13 | $3,777 | $252 |
| New patient problem focused exam of visual system | 38 | $2,331 | $61 |
| Removal of eyelashes using forceps | 19 | $2,045 | $44 |
| Microfluid analysis of tears | 39 | $1,811 | $22 |
| Ultrasound scan of cornea to determine thickness | 137 | $1,607 | $12 |
| Examination of eye by ophthalmoscope with retinal drawing | 28 | $683 | $22 |
2013: 25 services
| Established patient problem focused exam of visual system | 1,638 | $233,715 | $64 |
| Removal of cataract with insertion of prosthetic lens | 132 | $102,548 | $436 |
| Established patient complete exam of visual system | 935 | $85,633 | $90 |
| Exam of visual field with extended testing | 755 | $41,462 | $51 |
| New patient complete exam of visual system | 254 | $27,488 | $108 |
| Imaging of optic nerve | 742 | $25,755 | $33 |
| Internal insertion of eye fluid drainage device | 20 | $25,016 | $807 |
| Complex removal of cataract with insertion of prosthetic lens | 27 | $19,213 | $291 |
| External insertion of eye fluid drainage device | 17 | $19,190 | $1,010 |
| Laser repair to improve eye fluid flow | 42 | $13,448 | $274 |
| Removal of recurring cataract in lens capsule using a laser | 45 | $12,671 | $253 |
| Exam of the internal drainage system of eye | 582 | $12,311 | $21 |
| Measurement of corneal curvature and depth of eye | 162 | $12,200 | $54 |
| Creation of shunt to improve eye fluid flow using tissue graft | 11 | $10,410 | $946 |
| Short return visit (20+ min) | 135 | $8,283 | $55 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 18 | $5,656 | $202 |
| Short return visit | 132 | $5,302 | $34 |
| Imaging of retina | 143 | $5,087 | $33 |
| Laser repair to improve eye fluid flow | 16 | $4,020 | $251 |
| Removal of eyelashes using forceps | 36 | $3,299 | $37 |
| New patient problem focused exam of visual system | 38 | $2,007 | $53 |
| Ultrasound scan of cornea to determine thickness | 149 | $1,715 | $11 |
| Simple or single drainage of skin abscess | 11 | $995 | $90 |
| Microfluid analysis of tears | 11 | $490 | $22 |
| Examination of eye by ophthalmoscope with retinal drawing | 23 | $405 | $18 |
Medicaid work
$326 in 2024
Medicaid paid $326 for 29 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 29 | $326 |
| 2024 | 29 | 1 | 16 | $326 |
| 2023 | 55 | 1 | 18 | $755 |
| 2022 | 43 | 1 | 19 | $501 |
| 2021 | 69 | 1 | 16 | $277 |
| 2020 | 46 | 1 | 19 | $1,070 |
| 2019 | 27 | 1 | 15 | $238 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 55 | $755 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 43 | $501 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 69 | $277 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 46 | $1,070 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 27 | $238 |
Drugs they prescribed that Part D paid
$1,222,828
Pharmacies billed $1,222,828 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,124) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,909 generic and 2,215 brand-name prescriptions · $1,222,828 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 620 | $388,266 | $626 |
| Vyzulta | 246 | $137,212 | $558 |
| Rocklatan | 167 | $133,556 | $800 |
| Rhopressa | 111 | $75,837 | $683 |
| Xiidra | 36 | $60,393 | $1,678 |
See all 43 drugs
| Lumigan | 620 | $388,266 | $626 |
| Vyzulta | 246 | $137,212 | $558 |
| Rocklatan | 167 | $133,556 | $800 |
| Rhopressa | 111 | $75,837 | $683 |
| Xiidra | 36 | $60,393 | $1,678 |
| Combigan | 121 | $58,859 | $486 |
| Restasis | 46 | $54,756 | $1,190 |
| Miebo | 25 | $29,006 | $1,160 |
| Simbrinza | 58 | $28,620 | $493 |
| Dorzolamide-Timolol | 130 | $28,527 | $219 |
| Alphagan P | 44 | $25,329 | $576 |
| Brinzolamide | 65 | $14,690 | $226 |
| Brimonidine Tartrate-Timolol | 78 | $14,204 | $182 |
| Travoprost | 77 | $12,566 | $163 |
| Timolol Maleate | 31 | $11,517 | $372 |
| Timoptic Ocudose | 13 | $10,536 | $810 |
| Cyclosporine | 18 | $9,113 | $506 |
| Tafluprost | 23 | $8,892 | $387 |
| Timolol Maleate | 462 | $8,705 | $19 |
| Latanoprost | 571 | $8,416 | $15 |
| Azopt | 11 | $7,626 | $693 |
| Bimatoprost | 66 | $6,996 | $106 |
| Dorzolamide-Timolol | 273 | $6,220 | $23 |
| Travatan Z | 11 | $6,037 | $549 |
| Prednisolone Acetate | 125 | $5,836 | $47 |
| Prolensa | 13 | $5,151 | $396 |
| Loteprednol Etabonate | 30 | $4,489 | $150 |
| Lotemax Sm | 13 | $3,786 | $291 |
| Dorzolamide | 77 | $1,950 | $25 |
| Acetazolamide Er | 40 | $1,891 | $47 |
| Difluprednate | 22 | $1,801 | $82 |
| Brimonidine | 75 | $1,683 | $22 |
| Fluorometholone | 17 | $1,484 | $87 |
| Atropine Sulfate | 41 | $1,401 | $34 |
| Acetazolamide | 28 | $1,358 | $48 |
| Moxifloxacin | 49 | $1,289 | $26 |
| Doxycycline Hyclate | 34 | $706 | $21 |
| Neomycin-Polymyxin-Dexameth | 43 | $583 | $14 |
| Tobramycin-Dexamethasone | 14 | $559 | $40 |
| Bacitracin | 11 | $542 | $49 |
| Acyclovir | 11 | $341 | $31 |
| Diclofenac | 39 | $331 | $8 |
| Erythromycin | 25 | $289 | $12 |
Year by year
| 2024 | 4,124 | 949 | 0% (0) | 54% | $1,222,828 |
| 2023 | 4,258 | 934 | 0% (0) | 57% | $1,496,963 |
| 2022 | 4,697 | 977 | 0% (0) | 61% | $1,498,809 |
| 2021 | 4,720 | 962 | 0% (0) | 67% | $1,473,438 |
| 2020 | 5,448 | 1,041 | 0% (0) | 67% | $1,422,873 |
| 2019 | 5,514 | 989 | 0% (0) | 69% | $1,325,926 |
| 2018 | 5,460 | 959 | 0% (0) | 68% | $1,063,629 |
| 2017 | 5,768 | 933 | None | 67% | $1,029,528 |
| 2016 | 5,999 | 942 | 0% (0) | 68% | $982,723 |
| 2015 | 5,606 | 873 | 0% (0) | 74% | $853,963 |
| 2014 | 5,301 | 847 | None | 73% | $712,989 |
| 2013 | 5,071 | 825 | 0% (0) | 71% | $572,663 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Lumigan | 673 | $453,463 | $674 |
| Vyzulta | 231 | $127,436 | $552 |
| Rocklatan | 155 | $121,131 | $781 |
| Combigan | 177 | $91,960 | $520 |
| Rhopressa | 126 | $86,070 | $683 |
| Xiidra | 52 | $78,154 | $1,503 |
| Restasis | 52 | $71,522 | $1,375 |
| Simbrinza | 69 | $37,016 | $536 |
| Brinzolamide | 64 | $28,319 | $442 |
| Alphagan P | 52 | $27,839 | $535 |
| Dorzolamide-Timolol | 102 | $21,006 | $206 |
| Cyclosporine | 23 | $19,954 | $868 |
| Brimonidine Tartrate-Timolol | 51 | $17,564 | $344 |
| Timolol Maleate | 30 | $16,119 | $537 |
| Latanoprost | 601 | $15,159 | $25 |
| Travoprost | 52 | $15,085 | $290 |
| Prolensa | 31 | $12,841 | $414 |
| Timolol Maleate | 463 | $12,350 | $27 |
| Timoptic Ocudose | 16 | $11,463 | $716 |
| Dorzolamide-Timolol | 291 | $10,094 | $35 |
| Tafluprost | 28 | $9,179 | $328 |
| Ilevro | 20 | $8,096 | $405 |
| Azopt | 11 | $7,249 | $659 |
| Difluprednate | 48 | $6,630 | $138 |
| Prednisolone Acetate | 124 | $6,202 | $50 |
| Loteprednol Etabonate | 24 | $5,135 | $214 |
| Bimatoprost | 39 | $4,999 | $128 |
| Brimonidine | 98 | $4,172 | $43 |
| Lotemax Sm | 16 | $4,136 | $259 |
| Dorzolamide | 110 | $3,788 | $34 |
| Acetazolamide | 27 | $2,929 | $108 |
| Atropine Sulfate | 40 | $1,749 | $44 |
| Doxycycline Hyclate | 31 | $1,369 | $44 |
| Fluorometholone | 16 | $1,323 | $83 |
| Moxifloxacin | 48 | $1,286 | $27 |
| Acetazolamide Er | 22 | $1,260 | $57 |
| Tobramycin-Dexamethasone | 12 | $676 | $56 |
| Erythromycin | 32 | $304 | $10 |
| Acyclovir | 12 | $279 | $23 |
| Diclofenac | 26 | $265 | $10 |
| Neomycin-Polymyxin-Dexameth | 15 | $191 | $13 |
2022: 43 drugs
| Lumigan | 797 | $484,556 | $608 |
| Vyzulta | 221 | $120,524 | $545 |
| Combigan | 227 | $108,181 | $477 |
| Rhopressa | 144 | $103,092 | $716 |
| Rocklatan | 134 | $81,988 | $612 |
| Restasis | 55 | $77,542 | $1,410 |
| Xiidra | 55 | $71,360 | $1,297 |
| Simbrinza | 96 | $43,123 | $449 |
| Brinzolamide | 81 | $37,665 | $465 |
| Alphagan P | 54 | $31,826 | $589 |
| Zioptan | 42 | $25,112 | $598 |
| Dorzolamide-Timolol | 119 | $24,961 | $210 |
| Timoptic Ocudose | 25 | $22,177 | $887 |
| Ilevro | 63 | $21,830 | $347 |
| Travoprost | 77 | $21,163 | $275 |
| Timolol Maleate | 38 | $19,736 | $519 |
| Prolensa | 47 | $17,486 | $372 |
| Travatan Z | 29 | $16,484 | $568 |
| Latanoprost | 572 | $16,146 | $28 |
| Timolol Maleate | 459 | $16,081 | $35 |
| Brimonidine Tartrate-Timolol | 39 | $15,735 | $403 |
| Dorzolamide-Timolol | 262 | $13,212 | $50 |
| Prednisolone Acetate | 211 | $12,578 | $60 |
| Tyrvaya | 14 | $8,875 | $634 |
| Azopt | 17 | $8,720 | $513 |
| Loteprednol Etabonate | 30 | $6,453 | $215 |
| Moxifloxacin | 170 | $4,591 | $27 |
| Brimonidine | 83 | $4,502 | $54 |
| Difluprednate | 26 | $3,834 | $147 |
| Dorzolamide | 94 | $3,493 | $37 |
| Durezol | 15 | $3,367 | $224 |
| Lotemax Sm | 13 | $3,167 | $244 |
| Betimol | 12 | $2,901 | $242 |
| Acetazolamide | 22 | $2,822 | $128 |
| Pilocarpine | 24 | $1,880 | $78 |
| Acetazolamide Er | 28 | $1,706 | $61 |
| Atropine Sulfate | 44 | $1,673 | $38 |
| Tobramycin-Dexamethasone | 17 | $1,441 | $85 |
| Gatifloxacin | 25 | $1,350 | $54 |
| Doxycycline Hyclate | 20 | $1,273 | $64 |
| Fluorometholone | 11 | $1,099 | $100 |
| Erythromycin | 45 | $584 | $13 |
| Neomycin-Polymyxin-Dexameth | 12 | $188 | $16 |
2021: 46 drugs
| Lumigan | 828 | $462,101 | $558 |
| Combigan | 338 | $152,298 | $451 |
| Vyzulta | 212 | $104,157 | $491 |
| Rhopressa | 163 | $99,841 | $613 |
| Restasis | 60 | $72,242 | $1,204 |
| Rocklatan | 95 | $55,019 | $579 |
| Simbrinza | 133 | $46,427 | $349 |
| Azopt | 66 | $43,004 | $652 |
| Xiidra | 31 | $40,133 | $1,295 |
| Alphagan P | 61 | $39,889 | $654 |
| Dorzolamide-Timolol | 122 | $31,331 | $257 |
| Travoprost | 73 | $26,208 | $359 |
| Travatan Z | 53 | $25,511 | $481 |
| Zioptan | 55 | $22,052 | $401 |
| Latanoprost | 650 | $22,021 | $34 |
| Timoptic Ocudose | 27 | $19,348 | $717 |
| Brinzolamide | 37 | $18,018 | $487 |
| Prolensa | 45 | $14,448 | $321 |
| Dorzolamide-Timolol | 236 | $14,401 | $61 |
| Timolol Maleate | 27 | $13,546 | $502 |
| Besivance | 65 | $12,964 | $199 |
| Timolol Maleate | 437 | $12,940 | $30 |
| Bromsite | 30 | $8,267 | $276 |
| Durezol | 36 | $8,050 | $224 |
| Ilevro | 23 | $7,334 | $319 |
| Inveltys | 26 | $7,323 | $282 |
| Prednisolone Acetate | 135 | $7,140 | $53 |
| Cosopt Pf | 20 | $6,676 | $334 |
| Dorzolamide | 87 | $4,713 | $54 |
| Brimonidine | 72 | $4,535 | $63 |
| Lotemax | 13 | $4,254 | $327 |
| Loteprednol Etabonate | 20 | $4,213 | $211 |
| Istalol | 14 | $3,980 | $284 |
| Lotemax Sm | 16 | $3,678 | $230 |
| Betimol | 19 | $3,669 | $193 |
| Moxifloxacin | 87 | $3,221 | $37 |
| Acetazolamide | 21 | $2,729 | $130 |
| Pilocarpine | 22 | $1,845 | $84 |
| Atropine Sulfate | 36 | $1,647 | $46 |
| Doxycycline Hyclate | 28 | $1,543 | $55 |
| Valacyclovir | 11 | $1,305 | $119 |
| Bacitracin | 13 | $1,196 | $92 |
| Fluorometholone | 12 | $1,040 | $87 |
| Acetazolamide Er | 15 | $828 | $55 |
| Levobunolol | 14 | $524 | $37 |
| Erythromycin | 15 | $133 | $9 |
2020: 47 drugs
| Lumigan | 939 | $437,726 | $466 |
| Combigan | 394 | $158,461 | $402 |
| Rhopressa | 188 | $86,544 | $460 |
| Vyzulta | 204 | $79,250 | $388 |
| Azopt | 115 | $71,701 | $623 |
| Restasis | 48 | $61,697 | $1,285 |
| Travatan Z | 137 | $54,918 | $401 |
| Alphagan P | 118 | $44,893 | $380 |
| Simbrinza | 156 | $44,831 | $287 |
| Xiidra | 40 | $35,430 | $886 |
| Timoptic Ocudose | 57 | $35,176 | $617 |
| Latanoprost | 805 | $22,324 | $28 |
| Durezol | 89 | $19,235 | $216 |
| Rocklatan | 39 | $18,680 | $479 |
| Zioptan | 45 | $18,585 | $413 |
| Dorzolamide-Timolol | 62 | $17,015 | $274 |
| Dorzolamide-Timolol | 250 | $16,085 | $64 |
| Cosopt Pf | 48 | $15,537 | $324 |
| Besivance | 79 | $14,797 | $187 |
| Ilevro | 47 | $14,574 | $310 |
| Travoprost | 53 | $13,384 | $253 |
| Lotemax | 41 | $10,404 | $254 |
| Prolensa | 33 | $10,065 | $305 |
| Bromsite | 35 | $9,587 | $274 |
| Timolol Maleate | 448 | $9,572 | $21 |
| Brimonidine | 107 | $9,487 | $89 |
| Prednisolone Acetate | 183 | $9,397 | $51 |
| Methazolamide | 11 | $8,139 | $740 |
| Istalol | 19 | $7,890 | $415 |
| Acetazolamide | 45 | $7,328 | $163 |
| Dorzolamide | 114 | $4,819 | $42 |
| Pazeo | 17 | $4,589 | $270 |
| Betimol | 20 | $4,220 | $211 |
| Loteprednol Etabonate | 17 | $3,471 | $204 |
| Pilocarpine | 44 | $3,155 | $72 |
| Lotemax Sm | 12 | $2,784 | $232 |
| Moxifloxacin | 64 | $2,757 | $43 |
| Acetazolamide Er | 25 | $2,384 | $95 |
| Bacitracin | 22 | $2,267 | $103 |
| Atropine Sulfate | 36 | $1,776 | $49 |
| Tobramycin-Dexamethasone | 18 | $1,375 | $76 |
| Fluorometholone | 11 | $1,247 | $113 |
| Doxycycline Hyclate | 22 | $1,113 | $51 |
| Ketorolac Tromethamine | 14 | $553 | $40 |
| Levobunolol | 22 | $431 | $20 |
| Neomycin-Polymyxin-Dexameth | 16 | $283 | $18 |
| Erythromycin | 17 | $210 | $12 |
2019: 42 drugs
| Lumigan | 943 | $374,256 | $397 |
| Combigan | 436 | $153,062 | $351 |
| Travatan Z | 208 | $82,031 | $394 |
| Azopt | 164 | $75,800 | $462 |
| Rhopressa | 174 | $70,198 | $403 |
| Restasis | 58 | $68,002 | $1,172 |
| Vyzulta | 130 | $54,460 | $419 |
| Alphagan P | 142 | $49,898 | $351 |
| Simbrinza | 191 | $45,723 | $239 |
| Zioptan | 81 | $29,081 | $359 |
| Besivance | 123 | $21,488 | $175 |
| Timoptic Ocudose | 38 | $21,268 | $560 |
| Cosopt Pf | 67 | $21,227 | $317 |
| Xiidra | 25 | $20,325 | $813 |
| Latanoprost | 797 | $20,149 | $25 |
| Durezol | 90 | $18,327 | $204 |
| Lotemax | 65 | $17,531 | $270 |
| Ilevro | 47 | $16,166 | $344 |
| Dorzolamide-Timolol | 249 | $14,463 | $58 |
| Prolensa | 40 | $13,210 | $330 |
| Timolol Maleate | 387 | $12,051 | $31 |
| Prednisolone Acetate | 223 | $11,921 | $53 |
| Bromsite | 38 | $10,374 | $273 |
| Rocklatan | 17 | $10,070 | $592 |
| Brimonidine | 93 | $8,450 | $91 |
| Istalol | 26 | $8,358 | $321 |
| Dorzolamide-Timolol | 36 | $7,396 | $205 |
| Pazeo | 29 | $6,794 | $234 |
| Dorzolamide | 146 | $6,230 | $43 |
| Acetazolamide | 21 | $3,876 | $185 |
| Azasite | 14 | $3,013 | $215 |
| Pilocarpine | 38 | $2,701 | $71 |
| Bacitracin | 23 | $2,405 | $105 |
| Atropine Sulfate | 47 | $1,866 | $40 |
| Fluorometholone | 20 | $1,521 | $76 |
| Valacyclovir | 20 | $1,405 | $70 |
| Acetazolamide Er | 13 | $1,292 | $99 |
| Doxycycline Hyclate | 22 | $958 | $44 |
| Moxifloxacin | 15 | $677 | $45 |
| Olopatadine | 11 | $551 | $50 |
| Acyclovir | 15 | $405 | $27 |
| Levobunolol | 20 | $265 | $13 |
2018: 39 drugs
| Lumigan | 1,045 | $325,915 | $312 |
| Combigan | 456 | $134,966 | $296 |
| Travatan Z | 222 | $81,268 | $366 |
| Azopt | 168 | $65,130 | $388 |
| Restasis | 63 | $54,145 | $859 |
| Alphagan P | 170 | $48,706 | $287 |
| Simbrinza | 190 | $41,000 | $216 |
| Cosopt Pf | 148 | $32,874 | $222 |
| Zioptan | 110 | $31,452 | $286 |
| Latanoprost | 936 | $18,636 | $20 |
| Timoptic Ocudose | 41 | $18,564 | $453 |
| Lotemax | 73 | $17,513 | $240 |
| Rhopressa | 48 | $15,871 | $331 |
| Besivance | 96 | $15,671 | $163 |
| Xiidra | 23 | $14,416 | $627 |
| Vyzulta | 33 | $13,655 | $414 |
| Prednisolone Acetate | 233 | $12,056 | $52 |
| Prolensa | 39 | $10,085 | $259 |
| Methazolamide | 11 | $9,435 | $858 |
| Durezol | 45 | $9,162 | $204 |
| Brimonidine | 107 | $8,673 | $81 |
| Timolol Maleate | 395 | $7,928 | $20 |
| Ilevro | 28 | $7,820 | $279 |
| Istalol | 22 | $6,691 | $304 |
| Dorzolamide-Timolol | 208 | $6,689 | $32 |
| Pazeo | 28 | $6,529 | $233 |
| Bromsite | 21 | $5,693 | $271 |
| Acetazolamide | 32 | $4,734 | $148 |
| Pilocarpine | 47 | $3,327 | $71 |
| Bacitracin | 28 | $2,917 | $104 |
| Dorzolamide | 104 | $2,523 | $24 |
| Vigamox | 12 | $1,983 | $165 |
| Valacyclovir | 15 | $1,642 | $109 |
| Olopatadine | 15 | $1,285 | $86 |
| Atropine Sulfate | 32 | $1,154 | $36 |
| Moxifloxacin | 15 | $829 | $55 |
| Doxycycline Hyclate | 34 | $746 | $22 |
| Acyclovir | 15 | $250 | $17 |
| Levobunolol | 16 | $201 | $13 |
2017: 34 drugs
| Lumigan | 1,166 | $331,423 | $284 |
| Combigan | 483 | $122,464 | $254 |
| Travatan Z | 236 | $74,635 | $316 |
| Azopt | 184 | $70,880 | $385 |
| Restasis | 97 | $61,774 | $637 |
| Alphagan P | 192 | $53,035 | $276 |
| Zioptan | 147 | $35,842 | $244 |
| Simbrinza | 189 | $34,234 | $181 |
| Cosopt Pf | 163 | $32,113 | $197 |
| Timoptic Ocudose | 42 | $17,177 | $409 |
| Latanoprost | 971 | $17,148 | $18 |
| Lotemax | 86 | $16,854 | $196 |
| Ilevro | 51 | $14,224 | $279 |
| Besivance | 93 | $13,858 | $149 |
| Prednisolone Acetate | 236 | $13,623 | $58 |
| Durezol | 61 | $11,323 | $186 |
| Methazolamide | 18 | $11,107 | $617 |
| Dorzolamide-Timolol | 291 | $8,992 | $31 |
| Brimonidine | 84 | $8,382 | $100 |
| Istalol | 26 | $7,866 | $303 |
| Acetazolamide | 44 | $6,900 | $157 |
| Prolensa | 26 | $6,072 | $234 |
| Timolol Maleate | 312 | $5,730 | $18 |
| Pazeo | 30 | $5,277 | $176 |
| Vigamox | 31 | $5,120 | $165 |
| Dorzolamide | 145 | $3,712 | $26 |
| Bacitracin | 35 | $3,309 | $95 |
| Betimol | 21 | $3,236 | $154 |
| Pilocarpine | 46 | $3,010 | $65 |
| Atropine Sulfate | 15 | $554 | $37 |
| Doxycycline Hyclate | 24 | $495 | $21 |
| Acyclovir | 19 | $435 | $23 |
| Neomycin-Polymyxin-Dexameth | 15 | $252 | $17 |
| Erythromycin | 19 | $148 | $8 |
2016: 37 drugs
| Lumigan | 1,247 | $322,039 | $258 |
| Combigan | 460 | $98,908 | $215 |
| Azopt | 185 | $66,348 | $359 |
| Travatan Z | 225 | $63,829 | $284 |
| Zioptan | 217 | $48,347 | $223 |
| Restasis | 83 | $46,993 | $566 |
| Alphagan P | 195 | $41,289 | $212 |
| Cosopt Pf | 225 | $40,317 | $179 |
| Simbrinza | 199 | $32,594 | $164 |
| Ilevro | 100 | $24,886 | $249 |
| Timoptic Ocudose | 44 | $16,663 | $379 |
| Besivance | 112 | $15,325 | $137 |
| Lotemax | 81 | $15,067 | $186 |
| Latanoprost | 978 | $14,661 | $15 |
| Methazolamide | 33 | $14,399 | $436 |
| Prednisolone Acetate | 199 | $14,277 | $72 |
| Acetazolamide | 57 | $10,268 | $180 |
| Durezol | 61 | $9,847 | $161 |
| Prolensa | 43 | $9,200 | $214 |
| Istalol | 27 | $7,591 | $281 |
| Dorzolamide-Timolol | 300 | $7,298 | $24 |
| Brimonidine | 63 | $6,687 | $106 |
| Vigamox | 43 | $6,487 | $151 |
| Pataday | 31 | $5,197 | $168 |
| Timolol Maleate | 298 | $5,131 | $17 |
| Pazeo | 30 | $4,916 | $164 |
| Bacitracin | 33 | $3,619 | $110 |
| Pilocarpine | 38 | $3,132 | $82 |
| Xalatan | 12 | $3,131 | $261 |
| Dorzolamide | 141 | $3,054 | $22 |
| Tobradex | 11 | $2,044 | $186 |
| Betimol | 14 | $1,963 | $140 |
| Doxycycline Hyclate | 30 | $1,125 | $38 |
| Atropine Sulfate | 16 | $560 | $35 |
| Acyclovir | 20 | $559 | $28 |
| Erythromycin | 21 | $190 | $9 |
| Neomycin-Polymyxin-Dexameth | 11 | $178 | $16 |
2015: 37 drugs
| Lumigan | 1,312 | $282,847 | $216 |
| Combigan | 420 | $75,962 | $181 |
| Travatan Z | 246 | $57,316 | $233 |
| Azopt | 157 | $49,889 | $318 |
| Restasis | 101 | $47,898 | $474 |
| Zioptan | 208 | $36,131 | $174 |
| Alphagan P | 171 | $33,721 | $197 |
| Cosopt Pf | 192 | $28,722 | $150 |
| Simbrinza | 184 | $26,965 | $147 |
| Ilevro | 97 | $21,164 | $218 |
| Lotemax | 94 | $19,197 | $204 |
| Durezol | 116 | $17,275 | $149 |
| Timoptic Ocudose | 44 | $16,894 | $384 |
| Besivance | 121 | $16,495 | $136 |
| Prednisolone Acetate | 200 | $13,687 | $68 |
| Pataday | 59 | $12,203 | $207 |
| Methazolamide | 32 | $11,312 | $354 |
| Latanoprost | 758 | $10,303 | $14 |
| Istalol | 35 | $8,698 | $249 |
| Acetazolamide | 40 | $7,810 | $195 |
| Prolensa | 36 | $7,715 | $214 |
| Dorzolamide-Timolol | 254 | $7,222 | $28 |
| Brimonidine | 63 | $6,832 | $108 |
| Vigamox | 37 | $5,215 | $141 |
| Timolol Maleate | 236 | $4,274 | $18 |
| Xalatan | 18 | $3,488 | $194 |
| Bacitracin | 33 | $2,929 | $89 |
| Betimol | 15 | $2,387 | $159 |
| Doxycycline Hyclate | 30 | $2,203 | $73 |
| Dorzolamide | 81 | $2,070 | $26 |
| Tobradex | 11 | $2,040 | $185 |
| Fluorometholone | 19 | $1,749 | $92 |
| Pilocarpine | 11 | $816 | $74 |
| Acyclovir | 26 | $364 | $14 |
| Atropine Sulfate | 17 | $337 | $20 |
| Erythromycin | 25 | $272 | $11 |
| Neomycin-Polymyxin-Dexameth | 16 | $244 | $15 |
2014: 34 drugs
| Lumigan | 1,216 | $246,575 | $203 |
| Combigan | 352 | $63,029 | $179 |
| Travatan Z | 280 | $56,908 | $203 |
| Restasis | 82 | $36,579 | $446 |
| Alphagan P | 175 | $29,111 | $166 |
| Azopt | 105 | $26,652 | $254 |
| Zioptan | 166 | $24,546 | $148 |
| Cosopt Pf | 154 | $17,524 | $114 |
| Lotemax | 76 | $15,328 | $202 |
| Ilevro | 88 | $14,813 | $168 |
| Brimonidine | 103 | $13,921 | $135 |
| Simbrinza | 123 | $13,877 | $113 |
| Latanoprost | 735 | $12,869 | $18 |
| Besivance | 103 | $12,656 | $123 |
| Durezol | 94 | $12,136 | $129 |
| Istalol | 50 | $11,717 | $234 |
| Prednisolone Acetate | 146 | $11,530 | $79 |
| Timoptic Ocudose | 31 | $10,568 | $341 |
| Dorzolamide-Timolol | 357 | $10,502 | $29 |
| Prolensa | 52 | $10,137 | $195 |
| Pataday | 56 | $8,906 | $159 |
| Acetazolamide | 41 | $5,848 | $143 |
| Vigamox | 50 | $5,533 | $111 |
| Timolol Maleate | 239 | $4,613 | $19 |
| Xalatan | 27 | $4,075 | $151 |
| Alrex | 22 | $3,818 | $174 |
| Betimol | 22 | $3,175 | $144 |
| Methazolamide | 20 | $2,678 | $134 |
| Dorzolamide | 68 | $2,460 | $36 |
| Bacitracin | 30 | $2,327 | $78 |
| Doxycycline Hyclate | 22 | $1,425 | $65 |
| Pilocarpine | 15 | $1,133 | $76 |
| Atropine Sulfate | 26 | $586 | $23 |
| Neomycin-Polymyxin-Dexameth | 25 | $411 | $16 |
2013: 39 drugs
| Lumigan | 1,169 | $200,926 | $172 |
| Combigan | 333 | $51,597 | $155 |
| Travatan Z | 289 | $48,773 | $169 |
| Azopt | 147 | $27,683 | $188 |
| Restasis | 67 | $23,603 | $352 |
| Alphagan P | 164 | $23,224 | $142 |
| Latanoprost | 862 | $16,343 | $19 |
| Istalol | 81 | $14,726 | $182 |
| Zioptan | 103 | $14,506 | $141 |
| Cosopt Pf | 118 | $13,286 | $113 |
| Dorzolamide-Timolol | 324 | $11,753 | $36 |
| Lotemax | 67 | $10,802 | $161 |
| Brimonidine | 91 | $9,976 | $110 |
| Zymaxid | 85 | $9,117 | $107 |
| Pataday | 63 | $8,423 | $134 |
| Ilevro | 48 | $7,157 | $149 |
| Timoptic Ocudose | 22 | $7,123 | $324 |
| Besivance | 61 | $6,710 | $110 |
| Durezol | 53 | $5,952 | $112 |
| Bromday | 32 | $5,378 | $168 |
| Prednisolone Acetate | 148 | $5,171 | $35 |
| Acetazolamide | 41 | $4,802 | $117 |
| Timolol Maleate | 234 | $4,713 | $20 |
| Betimol | 34 | $3,544 | $104 |
| Dorzolamide | 73 | $3,107 | $43 |
| Bacitracin | 23 | $2,751 | $120 |
| Zylet | 14 | $2,512 | $179 |
| Xalatan | 21 | $2,375 | $113 |
| Doxycycline Hyclate | 32 | $2,364 | $74 |
| Alrex | 14 | $2,217 | $158 |
| Prolensa | 13 | $2,157 | $166 |
| Vigamox | 21 | $2,144 | $102 |
| Simbrinza | 20 | $2,003 | $100 |
| Lastacaft | 16 | $1,987 | $124 |
| Methazolamide | 18 | $1,405 | $78 |
| Atropine Sulfate | 18 | $262 | $15 |
| Acyclovir | 12 | $245 | $20 |
| Neomycin-Polymyxin-Dexameth | 14 | $230 | $16 |
| Erythromycin | 13 | $207 | $16 |
Money from drug and device companies
$269,624 in 2025
| 2025 | 14 | 303 | $245,898 | $269,624 |
| 2024 | 15 | 307 | $217,676 | $241,718 |
| 2023 | 16 | 272 | $228,421 | $252,865 |
| 2022 | 16 | 312 | $209,451 | $239,632 |
| 2021 | 20 | 270 | $205,913 | $217,357 |
| 2020 | 19 | 232 | $208,742 | $217,996 |
| 2019 | 18 | 366 | $180,988 | $216,257 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Vyzulta | $102,535 | 101 payments
|
| Alcon Vision | Rocklatan | $59,433 | 60 payments
|
| Abbvie | Durysta | $45,996 | 55 payments
|
| Sun Pharmaceutical Industries | Cequa | $28,223 | 46 payments
|
| Glaukos | Travoprost Intraocular Implant - Idose | $21,680 | 12 payments
|
| Sight Sciences | Omni Surgical System | $10,091 | 9 payments
|
See all 302 published payments
| Tarsus Pharmaceuticals | Meals · 2025-12-22 | Xdemvy | $17 |
| Alcon Vision | Paid to speak or teach · 2025-12-18 | Tryptyr | $5,500 |
| Alcon Vision | Travel · 2025-12-18 | Tryptyr | $98 |
| Alcon Vision | Travel · 2025-12-18 | Tryptyr | $132 |
| Abbvie | Meals · 2025-12-17 | Lumigan | $7 |
| Harrow Eye | Meals · 2025-12-16 | Vevye | $33 |
| Abbvie | Meals · 2025-12-15 | Durysta | $6 |
| Abbvie | Paid to speak or teach · 2025-12-11 | Xen Glaucoma Treatment System | $2,175 |
| Alcon Vision | Meals · 2025-12-11 | Tryptyr | $146 |
| Bausch & Lomb Americas | Meals · 2025-12-11 | Scoutpro Osmolarity System | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-12-09 | Cequa | $12 |
| Alcon Vision | Paid to speak or teach · 2025-12-04 | Rocklatan | $5,500 |
| Bausch & Lomb Americas | Meals · 2025-12-04 | Miebo | $6 |
| Thea Pharma | Meals · 2025-12-02 | Iyuzeh | $13 |
| Beaver-Visitec International | Meals · 2025-11-26 | None | $47 |
| Abbvie | Meals · 2025-11-25 | Lumigan | $3 |
| Abbvie | Meals · 2025-11-25 | Lumigan | $7 |
| Alcon Vision | Meals · 2025-11-20 | Rhopressa | $123 |
| Alcon Vision | Meals · 2025-11-20 | Rhopressa | $20 |
| Alcon Vision | Meals · 2025-11-20 | Rhopressa | $8 |
| Alcon Vision | Meals · 2025-11-20 | Rhopressa | $32 |
| Alcon Vision | Meals · 2025-11-20 | Rocklatan | $34 |
| Alcon Vision | Meals · 2025-11-20 | Rhopressa | $13 |
| Alcon Vision | Meals · 2025-11-20 | Rocklatan | $22 |
| Alcon Vision | Paid to speak or teach · 2025-11-20 | Rhopressa | $6,500 |
| Alcon Vision | Travel · 2025-11-20 | Rhopressa | $10 |
| Alcon Vision | Travel · 2025-11-20 | Rocklatan | $35 |
| Alcon Vision | Travel · 2025-11-20 | Rocklatan | $113 |
| Alcon Vision | Travel · 2025-11-20 | Rhopressa | $141 |
| Alcon Vision | Travel · 2025-11-20 | Rhopressa | $89 |
| Alcon Vision | Travel · 2025-11-20 | Rocklatan | $1,267 |
| Glaukos | Consulting · 2025-11-19 | Mitosol | $3,825 |
| Glaukos | Consulting · 2025-11-19 | None | $1,700 |
| Abbvie | Meals · 2025-11-17 | Durysta | $6 |
| Glaukos | Meals · 2025-11-17 | Idosetr | $35 |
| Sun Pharmaceutical Industries | Meals · 2025-11-11 | Cequa | $16 |
| Abbvie | Meals · 2025-11-07 | Lumigan | $77 |
| Abbvie | Meals · 2025-11-07 | Lumigan | $10 |
| Alcon Vision | Meals · 2025-11-06 | Rocklatan | $120 |
| Alcon Vision | Meals · 2025-11-06 | Rhopressa | $22 |
| Alcon Vision | Meals · 2025-11-06 | Rocklatan | $23 |
| Alcon Vision | Consulting · 2025-11-06 | Rhopressa | $1,000 |
| Alcon Vision | Paid to speak or teach · 2025-11-06 | Tryptyr | $3,500 |
| Alcon Vision | Paid to speak or teach · 2025-11-06 | Rhopressa | $6,500 |
| Alcon Vision | Consulting · 2025-11-06 | Rocklatan | $1,000 |
| Alcon Vision | Consulting · 2025-11-06 | Tryptyr | $6,000 |
| Alcon Vision | Travel · 2025-11-06 | Tryptyr | $41 |
| Alcon Vision | Travel · 2025-11-06 | Rhopressa | $27 |
| Alcon Vision | Travel · 2025-11-06 | Rocklatan | $27 |
| Alcon Vision | Travel · 2025-11-06 | Rocklatan | $38 |
| Alcon Vision | Travel · 2025-11-06 | Rhopressa | $15 |
| Alcon Vision | Travel · 2025-11-06 | Rhopressa | $22 |
| Alcon Vision | Travel · 2025-11-06 | Rocklatan | $25 |
| Alcon Vision | Travel · 2025-11-06 | Rocklatan | $347 |
| Alcon Vision | Travel · 2025-11-06 | Rhopressa | $331 |
| Alcon Vision | Travel · 2025-11-06 | Rhopressa | $329 |
| Bausch & Lomb Americas | Consulting · 2025-11-05 | Vyzulta | $850 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-11-05 | Vyzulta | $6,800 |
| Abbvie | Consulting · 2025-11-03 | Durysta | $1,050 |
| Bausch & Lomb Americas | Consulting · 2025-11-01 | Vyzulta | $8,500 |
| Alcon Vision | Meals · 2025-10-30 | Rhopressa | $121 |
| Alcon Vision | Travel · 2025-10-30 | Rhopressa | $418 |
| Alcon Vision | Travel · 2025-10-30 | Rocklatan | $201 |
| Harrow Eye | Meals · 2025-10-29 | Vevye | $20 |
| Alcon Vision | Meals · 2025-10-27 | Tryptyr | $123 |
| Alcon Vision | Paid to speak or teach · 2025-10-23 | Rocklatan | $6,500 |
| Alcon Vision | Travel · 2025-10-23 | Rocklatan | $50 |
| Alcon Vision | Travel · 2025-10-23 | Rhopressa | $9 |
| Kowa Pharmaceuticals America | Honoraria · 2025-10-23 | None | $1,125 |
| Abbvie | Consulting · 2025-10-22 | Durysta | $700 |
| Sun Pharmaceutical Industries | Meals · 2025-10-21 | Cequa | $5 |
| Bausch & Lomb Americas | Travel · 2025-10-20 | Vyzulta | $208 |
| Bausch & Lomb Americas | Meals · 2025-10-20 | Vyzulta | $115 |
| Bausch & Lomb Americas | Travel · 2025-10-20 | Vyzulta | $220 |
| Bausch & Lomb Americas | Meals · 2025-10-20 | Vyzulta | $52 |
| Bausch & Lomb Americas | Travel · 2025-10-20 | Vyzulta | $198 |
| Bausch & Lomb Americas | Travel · 2025-10-20 | Vyzulta | $308 |
| Alcon Vision | Meals · 2025-10-17 | None | $89 |
| Harrow Eye | Meals · 2025-10-17 | None | $51 |
| Sun Pharmaceutical Industries | Meals · 2025-10-17 | Cequa | $10 |
| Bausch & Lomb Americas | Consulting · 2025-10-17 | Miebo | $71 |
| Bausch & Lomb Americas | Consulting · 2025-10-17 | Miebo | $1,700 |
| Alcon Vision | Meals · 2025-10-16 | Rocklatan | $122 |
| Thea Pharma | Meals · 2025-10-15 | Iyuzeh | $5 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-10-15 | Miebo | $1,700 |
| Abbvie | Consulting · 2025-10-10 | Durysta | $1,050 |
| Glaukos | Consulting · 2025-10-08 | Travoprost Intraocular Implant - Idose | $2,550 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-10-08 | Miebo | $5,550 |
| Amgen | Meals · 2025-10-07 | Tepezza | $15 |
| Abbvie | Meals · 2025-10-03 | Durysta | $6 |
| Abbvie | Consulting · 2025-10-03 | Durysta | $1,050 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-10-01 | Miebo | $6,800 |
| Bausch & Lomb Americas | Meals · 2025-09-26 | Miebo | $14 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $353 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $11 |
| Bausch & Lomb Americas | Meals · 2025-09-25 | Miebo | $25 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $26 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $56 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $10 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $38 |
| Bausch & Lomb Americas | Meals · 2025-09-25 | Miebo | $125 |
| Bausch & Lomb Americas | Travel · 2025-09-25 | Miebo | $281 |
| Alcon Vision | Meals · 2025-09-23 | Rocklatan | $25 |
| Bausch & Lomb Americas | Travel · 2025-09-20 | Miebo | $56 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $99 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $17 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $12 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $79 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $12 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $20 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $80 |
| Bausch & Lomb Americas | Travel · 2025-09-20 | Miebo | $40 |
| Bausch & Lomb Americas | Meals · 2025-09-20 | Miebo | $13 |
| Bausch & Lomb Americas | Travel · 2025-09-19 | Miebo | $337 |
| Bausch & Lomb Americas | Travel · 2025-09-19 | Miebo | $10 |
| Bausch & Lomb Americas | Meals · 2025-09-19 | Miebo | $32 |
| Bausch & Lomb Americas | Travel · 2025-09-19 | Miebo | $29 |
| Bausch & Lomb Americas | Travel · 2025-09-19 | Miebo | $74 |
| Bausch & Lomb Americas | Meals · 2025-09-19 | Miebo | $16 |
| Bausch & Lomb Americas | Travel · 2025-09-19 | Miebo | $442 |
| Sight Sciences | Paid to speak or teach · 2025-09-18 | Omni Surgical System | $750 |
| Glaukos | Consulting · 2025-09-17 | None | $2,550 |
| Abbvie | Consulting · 2025-09-16 | Durysta | $7,613 |
| Abbvie | Meals · 2025-09-15 | Durysta | $6 |
| Abbvie | Consulting · 2025-09-11 | None | $1,813 |
| Alcon Vision | Meals · 2025-09-05 | Tryptyr | $18 |
| Bausch & Lomb Americas | Consulting · 2025-08-29 | None | $8,500 |
| Abbvie | Meals · 2025-08-26 | Durysta | $10 |
| Alcon Vision | Consulting · 2025-08-21 | Rhopressa | $1,000 |
| Abbvie | Meals · 2025-08-19 | Lumigan | $8 |
| Bausch & Lomb Americas | Meals · 2025-08-15 | Miebo | $23 |
| Abbvie | Paid to speak or teach · 2025-08-14 | Xen Glaucoma Treatment System | $2,175 |
| Alcon Vision | Meals · 2025-08-14 | Tryptyr | $14 |
| Bausch & Lomb Americas | Consulting · 2025-08-11 | None | $1,700 |
| Abbvie | Meals · 2025-08-07 | Durysta | $16 |
| Sun Pharmaceutical Industries | Travel · 2025-08-07 | Cequa | $98 |
| Sun Pharmaceutical Industries | Travel · 2025-08-07 | Cequa | $15 |
| Sun Pharmaceutical Industries | Travel · 2025-08-07 | Cequa | $100 |
| Sun Pharmaceutical Industries | Travel · 2025-08-07 | Cequa | $98 |
| Sun Pharmaceutical Industries | Meals · 2025-08-07 | Cequa | $36 |
| Thea Pharma | Meals · 2025-08-06 | Iyuzeh | $16 |
| Abbvie | Meals · 2025-07-30 | Lumigan | $7 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-07-30 | Cequa | $4,235 |
| Sun Pharmaceutical Industries | Travel · 2025-07-30 | Cequa | $712 |
| Sun Pharmaceutical Industries | Meals · 2025-07-30 | Cequa | $124 |
| Bausch & Lomb Americas | Meals · 2025-07-28 | Vyzulta | $21 |
| Harrow Eye | Meals · 2025-07-24 | Iheezo | $10 |
| Sun Pharmaceutical Industries | Travel · 2025-07-22 | Cequa | $66 |
| Sun Pharmaceutical Industries | Travel · 2025-07-22 | Cequa | $8 |
| Sun Pharmaceutical Industries | Travel · 2025-07-11 | Cequa | $267 |
| Alcon Vision | Paid to speak or teach · 2025-07-10 | Rocklatan | $5,500 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-07-10 | Cequa | $5,775 |
| Sun Pharmaceutical Industries | Travel · 2025-07-10 | Cequa | $397 |
| Sun Pharmaceutical Industries | Travel · 2025-07-10 | Cequa | $216 |
| Sun Pharmaceutical Industries | Meals · 2025-07-10 | Cequa | $120 |
| Bausch & Lomb Americas | Meals · 2025-07-10 | Miebo | $2 |
| Bausch & Lomb Americas | Meals · 2025-07-10 | Miebo | $5 |
| Bausch & Lomb Americas | Meals · 2025-07-10 | Miebo | $5 |
| Bausch & Lomb Americas | Meals · 2025-07-10 | Miebo | $4 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-07-10 | Vyzulta | $638 |
| Dompe US | Meals · 2025-07-01 | Oxervate | $31 |
| Sun Pharmaceutical Industries | Meals · 2025-06-30 | Cequa | $8 |
| Abbvie | Consulting · 2025-06-26 | Durysta | $400 |
| Abbvie | Consulting · 2025-06-26 | Durysta | $400 |
| Abbvie | Consulting · 2025-06-26 | Durysta | $300 |
| Alcon Vision | Meals · 2025-06-26 | Rocklatan | $125 |
| Alcon Vision | Travel · 2025-06-26 | Rhopressa | $1,189 |
| Bausch & Lomb Americas | Meals · 2025-06-26 | Miebo | $15 |
| Bausch & Lomb Americas | Meals · 2025-06-23 | Miebo | $22 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-06-23 | Miebo | $6,800 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-06-23 | Vyzulta | $6,800 |
| Abbvie | Consulting · 2025-06-20 | Durysta | $400 |
| Abbvie | Consulting · 2025-06-20 | Durysta | $300 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-06-19 | Cequa | $3,465 |
| Sun Pharmaceutical Industries | Meals · 2025-06-19 | Cequa | $122 |
| Sight Sciences | Meals · 2025-06-18 | Omni Surgical System | $20 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-06-16 | Vyzulta | $6,800 |
| Sun Pharmaceutical Industries | Consulting · 2025-06-12 | Cequa | $1,800 |
| Bausch & Lomb Americas | Consulting · 2025-06-12 | None | $17,000 |
| Bausch & Lomb Americas | Meals · 2025-06-06 | Miebo | $125 |
| Bausch & Lomb Americas | Travel · 2025-06-06 | Miebo | $183 |
| Bausch & Lomb Americas | Travel · 2025-06-06 | Miebo | $80 |
| Bausch & Lomb Americas | Travel · 2025-06-06 | Miebo | $342 |
| Bausch & Lomb Americas | Travel · 2025-06-05 | Vyzulta | $266 |
| Bausch & Lomb Americas | Meals · 2025-06-05 | Vyzulta | $122 |
| Bausch & Lomb Americas | Travel · 2025-06-05 | Vyzulta | $240 |
| Bausch & Lomb Americas | Travel · 2025-06-05 | Vyzulta | $120 |
| Bausch & Lomb Americas | Travel · 2025-06-05 | Vyzulta | $67 |
| Bausch & Lomb Americas | Travel · 2025-06-05 | Vyzulta | $853 |
| Bausch & Lomb Americas | Travel · 2025-06-05 | Vyzulta | $342 |
| Abbvie | Meals · 2025-05-31 | Lumigan | $9 |
| Abbvie | Meals · 2025-05-30 | Lumigan | $6 |
| Abbvie | Consulting · 2025-05-29 | None | $725 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $22 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $284 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $51 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $252 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $15 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $41 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $38 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $46 |
| Bausch & Lomb Americas | Travel · 2025-05-29 | Vyzulta | $9 |
| Bausch & Lomb Americas | Meals · 2025-05-29 | Vyzulta | $122 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-05-28 | Miebo | $850 |
| Alcon Vision | Meals · 2025-05-23 | Clareon | $29 |
| Alcon Vision | Consulting · 2025-05-22 | Rocklatan | $1,500 |
| Bausch & Lomb Americas | Consulting · 2025-05-20 | Vyzulta | $2,125 |
| Abbvie | Meals · 2025-05-19 | Durysta | $6 |
| Alcon Vision | Meals · 2025-05-13 | Rocklatan | $30 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-05-12 | Cequa | $1,540 |
| Bausch & Lomb Americas | Meals · 2025-05-12 | Miebo | $22 |
| Sight Sciences | Paid to speak or teach · 2025-05-08 | Omni Surgical System | $375 |
| Sun Pharmaceutical Industries | Meals · 2025-05-05 | Cequa | $7 |
| Thea Pharma | Meals · 2025-04-27 | None | $134 |
| Harrow Eye | Meals · 2025-04-25 | Vevye | $36 |
| Bausch & Lomb Americas | Consulting · 2025-04-25 | None | $850 |
| Bausch & Lomb Americas | Meals · 2025-04-24 | Miebo | $143 |
| Sun Pharmaceutical Industries | Travel · 2025-04-23 | Cequa | $69 |
| Sun Pharmaceutical Industries | Travel · 2025-04-23 | Cequa | $45 |
| Sun Pharmaceutical Industries | Travel · 2025-04-23 | Cequa | $38 |
| Sun Pharmaceutical Industries | Travel · 2025-04-23 | Cequa | $49 |
| Sun Pharmaceutical Industries | Travel · 2025-04-23 | Cequa | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-04-23 | Cequa | $39 |
| Sun Pharmaceutical Industries | Meals · 2025-04-23 | Cequa | $19 |
| Abbvie | Paid to speak or teach · 2025-04-18 | Durysta | $2,175 |
| Bausch & Lomb Americas | Consulting · 2025-04-11 | Vyzulta | $850 |
| Sight Sciences | Paid to speak or teach · 2025-04-10 | Omni Surgical System | $563 |
| Glaukos | Travel · 2025-04-09 | Travoprost Intraocular Implant - Idose | $691 |
| Sight Sciences | Paid to speak or teach · 2025-04-03 | Omni Surgical System | $3,750 |
| Sight Sciences | Paid to speak or teach · 2025-04-03 | Omni Surgical System | $4,600 |
| Thea Pharma | Meals · 2025-04-02 | Iyuzeh | $24 |
| Thea Pharma | Meals · 2025-04-02 | Iyuzeh | $3 |
| Sight Sciences | Meals · 2025-04-02 | Omni Surgical System | $7 |
| Bausch & Lomb Americas | Meals · 2025-03-31 | Miebo | $23 |
| Bausch & Lomb Americas | Consulting · 2025-03-26 | Vyzulta | $1,275 |
| Harrow Eye | Meals · 2025-03-25 | Vevye | $37 |
| Abbvie | Meals · 2025-03-24 | Durysta | $6 |
| Alcon Vision | Consulting · 2025-03-20 | Rhopressa | $1,500 |
| Abbvie | Consulting · 2025-03-19 | Durysta | $2,900 |
| Abbvie | Paid to speak or teach · 2025-03-18 | Durysta | $5,075 |
| Glaukos | Consulting · 2025-03-12 | Travoprost Intraocular Implant - Idose | $9,600 |
| Abbvie | Meals · 2025-03-10 | Durysta | $6 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-03-06 | Cequa | $5,250 |
| Sun Pharmaceutical Industries | Travel · 2025-03-06 | Cequa | $330 |
| Sun Pharmaceutical Industries | Travel · 2025-03-06 | Cequa | $267 |
| Sun Pharmaceutical Industries | Meals · 2025-03-06 | Cequa | $122 |
| Glaukos | Meals · 2025-03-05 | Travoprost Intraocular Implant - Idose | $357 |
| Glaukos | Travel · 2025-03-05 | Travoprost Intraocular Implant - Idose | $269 |
| Abbvie | Paid to speak or teach · 2025-03-04 | Durysta | $5,075 |
| Glaukos | Meals · 2025-03-03 | None | $31 |
| Abbvie | Consulting · 2025-03-02 | Durysta | $400 |
| Sun Pharmaceutical Industries | Meals · 2025-03-01 | Xelpros | $65 |
| Abbvie | Meals · 2025-02-28 | Durysta | $70 |
| Bausch & Lomb Americas | Meals · 2025-02-27 | Vyzulta | $133 |
| Bausch & Lomb Americas | Consulting · 2025-02-27 | Vyzulta | $2,550 |
| Bausch & Lomb Americas | Meals · 2025-02-26 | Xiidra | $100 |
| Bausch & Lomb Americas | Meals · 2025-02-25 | Scoutpro Osmolarity System | $16 |
| Abbvie | Meals · 2025-02-19 | Lumigan | $7 |
| Bausch & Lomb Americas | Paid to speak or teach · 2025-02-18 | Miebo | $3,400 |
| Abbvie | Paid to speak or teach · 2025-02-17 | Durysta | $2,175 |
| Abbvie | Meals · 2025-02-14 | Xen Glaucoma Treatment System | $113 |
| Abbvie | Meals · 2025-02-13 | Durysta | $25 |
| Abbvie | Travel · 2025-02-13 | Durysta | $121 |
| Abbvie | Travel · 2025-02-13 | Durysta | $687 |
| Abbvie | Meals · 2025-02-13 | Durysta | $114 |
| Abbvie | Travel · 2025-02-13 | Durysta | $797 |
| Abbvie | Travel · 2025-02-13 | Durysta | $190 |
| Abbvie | Consulting · 2025-02-10 | Durysta | $725 |
| Bausch & Lomb Americas | Meals · 2025-02-10 | Vyzulta | $35 |
| Abbvie | Meals · 2025-02-06 | Durysta | $8 |
| Bausch & Lomb Americas | Meals · 2025-02-06 | Miebo | $6 |
| Bausch & Lomb Americas | Travel · 2025-02-06 | Miebo | $15 |
| Bausch & Lomb Americas | Travel · 2025-02-06 | Miebo | $796 |
| Bausch & Lomb Americas | Meals · 2025-02-06 | Miebo | $125 |
| Abbvie | Consulting · 2025-02-05 | None | $4,713 |
| Bausch & Lomb Americas | Meals · 2025-02-05 | Miebo | $44 |
| Abbvie | Meals · 2025-02-04 | Lumigan | $26 |
| Sight Sciences | Meals · 2025-02-04 | Omni Surgical System | $4 |
| Sight Sciences | Meals · 2025-01-28 | Omni Surgical System | $22 |
| Abbvie | Meals · 2025-01-22 | Durysta | $126 |
| Glaukos | Meals · 2025-01-21 | Idosetr | $38 |
| Abbvie | Meals · 2025-01-20 | Durysta | $66 |
| Abbvie | Meals · 2025-01-20 | Durysta | $52 |
| Oyster Point Pharma | Meals · 2025-01-20 | Tyrvaya | $45 |
| Sun Pharmaceutical Industries | Meals · 2025-01-20 | Cequa | $90 |
| Sun Pharmaceutical Industries | Meals · 2025-01-20 | Cequa | $9 |
| Alcon Vision | Meals · 2025-01-19 | Eysuvis | $118 |
| Alcon Vision | Meals · 2025-01-19 | None | $103 |
| Bausch & Lomb Americas | Travel · 2025-01-19 | None | $93 |
| Bausch & Lomb Americas | Consulting · 2025-01-19 | None | $1,700 |
| Bausch & Lomb Americas | Meals · 2025-01-19 | None | $33 |
| Sun Pharmaceutical Industries | Consulting · 2025-01-16 | Xelpros | $2,250 |
| Sun Pharmaceutical Industries | Travel · 2025-01-14 | Cequa | $47 |
| Sun Pharmaceutical Industries | Meals · 2025-01-14 | Cequa | $17 |
| Sun Pharmaceutical Industries | Travel · 2025-01-14 | Cequa | $133 |
| Sun Pharmaceutical Industries | Travel · 2025-01-14 | Cequa | $47 |
| Sun Pharmaceutical Industries | Travel · 2025-01-14 | Cequa | $53 |
| Sun Pharmaceutical Industries | Meals · 2025-01-14 | Cequa | $24 |
| Abbvie | Meals · 2025-01-13 | Durysta | $6 |
| Alcon Vision | Consulting · 2025-01-09 | Rhopressa | $1,500 |
| Glaukos | Meals · 2025-01-09 | None | $35 |
| Thea Pharma | Meals · 2025-01-08 | Iyuzeh | $5 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $241,718
| Bausch & Lomb Americas | Vyzulta | $61,465 | 95 payments
|
| Abbvie | Durysta | $52,690 | 70 payments
|
| Glaukos | Idose | $44,431 | 26 payments
|
| Alcon Vision | Rhopressa | $35,120 | 38 payments
|
| Sun Pharmaceutical Industries | Cequa | $21,935 | 25 payments
|
| Thea Pharma | Iyuzeh | $9,979 | 16 payments
|
| Sight Sciences | Omni Surgical System | $6,236 | 17 payments
|
| Alcon Research | Rocklatan | $4,500 | 1 payment
|
| Dompe US | Oxervate | $2,668 | 4 payments
|
| Harrow Eye | Vevye | $2,089 | 4 payments
|
| New World Medical | Kahook Dual Blade | $409 | 3 payments
|
| Amgen | Tepezza | $56 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $51 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $47 | 2 payments
|
| Biotissue Holdings | None | $41 | 2 payments
|
2023: $252,865
| AbbVie | Durysta | $120,449 | 116 payments
|
| Thea Pharma | Iyuzeh | $30,575 | 12 payments
|
| Alcon Vision | Rocklatan | $19,730 | 37 payments
|
| Bausch & Lomb Americas | Miebo | $17,589 | 32 payments
|
| Glaukos | Istent Infinite Trabecular Micro-Bypass System Model Is3 | $16,566 | 15 payments
|
| Sight Sciences | Omni Surgical System | $15,272 | 16 payments
|
| Sun Pharmaceutical Industries | Cequa | $11,721 | 20 payments
|
| Alcon Research | Rocklatan | $6,931 | 4 payments
|
| Carl Zeiss Meditec | Artevo 800 | $4,200 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $3,762 | 9 payments
|
| Horizon Therapeutics plc | Tepezza | $3,088 | 4 payments
|
| Dompe US | Oxervate | $2,295 | 2 payments
|
| EyePoint Pharmaceuticals US | Yutiq | $525 | 1 payment
|
| Harrow Eye | Iheezo | $125 | 1 payment
|
| Beaver-Visitec International | None | $25 | 1 payment
|
| New World Medical | None | $13 | 1 payment
|
2022: $239,632
| Allergan | Durysta | $76,953 | 110 payments
|
| Abbvie | Durysta | $70,310 | 75 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $29,826 | 27 payments
|
| Sun Pharmaceutical Industries | Cequa | $28,704 | 33 payments
|
| Alcon Vision | Rhopressa | $18,080 | 18 payments
|
| Bausch & Lomb Americas | Vyzulta | $5,898 | 11 payments
|
| Oyster Point Pharma | Tyrvaya | $3,750 | 5 payments
|
| EyePoint Pharmaceuticals US | Yutiq | $3,126 | 3 payments
|
| Alcon Research | Ilux | $1,425 | 2 payments
|
| Glaukos | Istent Inject W | $1,052 | 10 payments
|
| Kala Pharmaceuticals | Inveltys | $130 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $122 | 12 payments
|
| Ocular Therapeutix | Dextenza | $117 | 1 payment
|
| BioTissue Holdings | Prokera | $49 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $46 | 2 payments
|
| Eyevance Pharmaceuticals | Zerviate | $45 | 1 payment
|
2021: $217,357
| Allergan | Durysta | $124,942 | 159 payments
|
| Aerie Pharmaceuticals | Rocklatan | $33,076 | 10 payments
|
| EyePoint Pharmaceuticals US | Dexycu | $25,426 | 11 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $12,035 | 27 payments
|
| Sun Pharmaceutical Industries | Cequa | $5,877 | 6 payments
|
| Iridex | None | $3,600 | 3 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $3,151 | 5 payments
|
| Eyevance Pharmaceuticals | Zerviate | $2,090 | 3 payments
|
| Omeros | Omidria | $1,935 | 2 payments
|
| Topcon Medical Systems | None | $1,562 | 2 payments
|
| Kala Pharmaceuticals | Eysuvis | $1,533 | 7 payments
|
| Glaukos | Istent Inject W | $1,372 | 4 payments
|
| Carl Zeiss Meditec USA | Iolmaster 700 | $293 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $122 | 18 payments
|
| Mallinckrodt Hospital Products | Acthar | $98 | 1 payment
|
| Tissuetech | Prokera | $95 | 3 payments
|
| Alcon Vision | Argos | $76 | 4 payments
|
| New World Medical | Ahmed Glaucoma Valve | $39 | 2 payments
|
| Dompe US | Oxervate | $20 | 1 payment
|
| Ocular Therapeutix | Dextenza | $17 | 1 payment
|
2020: $217,996
| Allergan | Durysta | $111,042 | 136 payments
|
| Aerie Pharmaceuticals | Rocklatan | $42,269 | 22 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $28,011 | 33 payments
|
| Sun Pharmaceutical Industries | Cequa | $12,954 | 12 payments
|
| Osmotica Pharmaceutical | None | $5,479 | 1 payment
|
| Iridex | None | $5,100 | 3 payments
|
| Vertical Pharmaceuticals | None | $4,750 | 2 payments
|
| EyePoint Pharmaceuticals US | Dexycu | $3,591 | 5 payments
|
| Glaukos | Istent Inject Trabecular Micro-Bypass Stent System | $1,534 | 4 payments
|
| Eyevance Pharmaceuticals | Tobradex St | $1,215 | 2 payments
|
| Omeros | Omidria | $650 | 1 payment
|
| Carl Zeiss Meditec | Cirrus Hd-Oct | $600 | 1 payment
|
| Sight Sciences | Omni | $525 | 2 payments
|
| Alcon Vision | Centurion | $101 | 1 payment
|
| New World Medical | Ahmed Glaucoma Valve | $65 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $52 | 3 payments
|
| Dompe US | Oxervate | $27 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $13 | 1 payment
|
2019: $216,257
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $59,525 | 80 payments
|
| Aerie Pharmaceuticals | Rhopressa | $55,605 | 81 payments
|
| Allergan | Lumigan | $51,214 | 122 payments
|
| Novartis Pharmaceuticals | Travatan Z | $18,903 | 26 payments
|
| Sun Pharmaceutical Industries | Cequa | $10,832 | 13 payments
|
| EyePoint Pharmaceuticals US | Dexycu | $7,264 | 11 payments
|
| Eyevance Pharmaceuticals | Flarex | $5,607 | 5 payments
|
| W. L. Gore & Associates | Product in Development | $1,950 | 2 payments
|
| Glaukos | Istent Inject Trabecular Micro-Bypass Stent System | $1,900 | 3 payments
|
| New World Medical | Ahmed Glaucoma Valve | $1,845 | 4 payments
|
| Optovue | Angiovue | $1,100 | 1 payment
|
| Alcon Vision | Restor | $221 | 5 payments
|
| TissueTech | Prokera | $91 | 2 payments
|
| Sight Sciences | Omni | $68 | 7 payments
|
| Omeros | Omidria | $50 | 1 payment
|
| Iridex | None | $42 | 1 payment
|
| Dompe US | Oxervate | $20 | 1 payment
|
| Osmotica Pharmaceutical | None | $19 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Ocular Therapeutix, Inc. · A Prospective Multicenter Open Label Study To Evaluate the Safety Tolerability and Efficacy of Otx Tic Implant in Subjects With Primary Open Angle Glaucoma Or Ocular Hypertension · 2020 | Their institution | $75,992 |
| GLAUKOS CORPORATION · 2022 | Their institution | $54,635 |
| Oyster Point Pharma, Inc. · A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study To Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (Mr-139), in Subjects With Blepharitis · 2025 | Their institution | $48,217 |
| Novartis Pharmaceuticals Corporation · A Randomized, Double-Masked, Multicenter Study To Evaluate the Safety and Efficacy of Ecf843 Vs Vehicle in Subjects With Dry Eye Disease · 2021 | Their institution | $47,820 |
| Aerie Pharmaceuticals, Inc. · A Multicenter, Open-Label Study of Rhopressa (Netarsudil Ophthalmic Solution) 0.02% for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma Or Ocular Hypertension in A Real-World Setting · 2019 | Their institution | $43,808 |
| Padagis US LLC · Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study To Compare Perrigo'S Brinzolamide Brimonidine Ophthalmic Suspension 1 Percent To Simbrinza in the Treatment of Primary Open Angle Glaucoma Or Ocular Hypertension in Both Eyes · 2022 | Their institution | $39,376 |
| Oyster Point Pharma, Inc. · A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study To Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (Mr-139), in Subjects With Blepharitis · 2024 | Their institution | $39,023 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5 · 2019 | Their institution | $36,076 |
| TOPCON HEALTHCARE SOLUTIONS, INC. · Trk-2p · 2021 | Their institution | $30,495 |
| Sun Pharmaceutical Industries Inc. · A Phase 3, Multicenter, Randomized, Double-Masked, Parallel-Group, Comparative Study To Evaluate the Clinical Efficacy and Safety of Isv-305 (0.1% Dexamethasone) Compared To Vehicle in the Treatment of Subjects With Blepharitis · 2020 | Their institution | $30,099 |
| Allergan, Inc. · The Efficacy and Safety of Bimatoprost Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2020 | Their institution | $26,165 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5 · 2021 | Their institution | $24,328 |
| Alcon Research LLC · A Multicenter, Open-Label Rocklatan (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% Evaluation of Iop Lowering Efficacy and Safety As Replacement of Current Medical Therapy Regimen for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma Or Ocular Hypertension / More · 2022 | Their institution | $23,478 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5% · 2020 | Their institution | $19,240 |
| Perrigo Company plc · Bioequivalence Study Between Perrigo'S Product and Azopt Ophthalmic Suspension · 2019 | Their institution | $17,870 |
| Ocular Therapeutix, Inc. · A Prospective, Multi-Center, Randomized, Parallel-Group, Controlled Study To Evaluate the Efficacy and Safety of Otx-Tic (Travoprost) Intracameral Implant in Subjects With Open-Angle Glaucoma (Oag) Or Ocular Hypertension (Oht) · 2024 | Their institution | $16,803 |
| Glaukos Corporation · Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant · 2021 | Their institution | $15,775 |
| Allergan Inc. · A Comparison of Bimatoprost Sr To Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $15,664 |
| Ocular Therapeutix, Inc. · A Prospective, Multi-Center, Randomized, Parallel-Group, Controlled Study To Evaluate the Efficacy and Safety of Otx-Tic (Travoprost) Intracameral Implant in Subjects With Open-Angle Glaucoma (Oag) Or Ocular Hypertension (Oht) · 2023 | Their institution | $14,384 |
| ABBVIE INC. · Long-Term Safety and Efficacy Extension Trial of Bimatoprost Sr · 2023 | Their institution | $12,762 |
| Amneal Pharmaceuticals LLC · Bimatoprost · 2023 | Their institution | $12,202 |
| Glaukos Corporation · Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants To Timolol Maleate Ophthalmic Solution, Usp, 0.5 · 2019 | Their institution | $11,901 |
| Allergan Inc. · The Efficacy and Safety of Bimatoprost Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $11,649 |
| Bausch Health US, LLC · A Randomized, Double-Masked, Active-Controlled, Parallel Group, Multi-Center Bioequivelence Study of the Generic Brinzolamide 1 Ophthalmic Suspension Compared To Branded Brinzolamide 1 Ophthalmic Suspension Azopt in Subjects With Primary Open Angle Glaucoma Or Ocular Hypertension · 2019 | This clinician | $11,612 |
| Sun Pharmaceutical Industries Inc. · A Phase 3, Randomized, Multicenter, Double-Masked Study To Compare the Ocular Safety, Tolerability, and Efficacy of Isv-305 (0.1% Dexamethasone in Durasite 2) To Durasite 2 Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery · 2020 | Their institution | $11,023 |
| Osmotica Pharmaceutical Corp. · 2019 | Their institution | $10,982 |
| ABBVIE INC. · A Study To Assess Adverse Events and Effectiveness of Gel Stent (Xen63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · 2025 | Their institution | $10,315 |
| Alcon Research LLC · A Multicenter, Open-Label Rocklatan Evaluation of Iop Lowering Efficacy and Safety As Replacement of Current Medical Therapy Regimen for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma Or Ocular Hypertension · 2023 | Their institution | $10,015 |
| Bausch Health US, LLC · A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial To Evaluate the Effect of Nov03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study) · 2021 | Their institution | $8,131 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5% · 2023 | Their institution | $7,023 |
| Allergan, Inc. · A Multicenter, Single-Masked, Randomized Study To Compare the Safety and Efficacy of Two Novel Artificial Tear Formulations With Systane Unit Dose for 3 Months in Subjects With Dry Eye Disease · 2020 | Their institution | $6,722 |
| EyePoint Pharmaceuticals US, Inc. · Dexycu Retrospective Study · 2020 | Their institution | $6,250 |
| Allergan, Inc. · 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (Durysta) · 2021 | Their institution | $5,566 |
| Allergan, Inc. · 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (Durysta) · 2022 | Their institution | $3,767 |
| Allergan Inc. · Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $3,312 |
| Ocular Therapeutix, Inc. · A Prospective, Multi-Center, Randomized, Parallel-Group, Controlled Study To Evaluate the Efficacy and Safety of Otx-Tic (Travoprost) Intracameral Implant in Subjects With Open-Angle Glaucoma (Oag) Or Ocular Hypertension (Oht) · 2022 | Their institution | $3,250 |
| Sight Sciences, Inc. · A Clinical Trial Comparing the Omni Surgical System To Standard Medical Treatment in Patients With Primary Open Angle Glaucoma (Evolve) · 2025 | Their institution | $3,000 |
| TOPCON MEDICAL SYSTEMS, INC. · Topcon Maestro2 Oct Angiography Software Evaluation Study · 2023 | This clinician | $2,800 |
| Allergan, Inc. · A Multicenter, Single-Masked, Randomized Study To Compare the Safety and Efficacy of Two Novel Artificial Tear Formulations With Systane Unit Dose for 3 Months Multicenter, Single-Masked, Randomized Study To Compare the Safety and Efficacy of Two Novel Artificial Tear Formulations With Systane Unit Dose for 3 Months in Subjects With Dry Eye Disease · 2020 | Their institution | $2,585 |
| Glaukos Corporation · Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants To Timolol Maleate Ophthalmic Solution, Usp, 0.5% · 2020 | Their institution | $2,320 |
| Allergan, Inc. · A Comparison of Bimatoprost Sr To Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2020 | Their institution | $2,183 |
| Shire North American Group Inc · A Phase 3, Multi-Center, Randomized, Double-Masked Study To Evaluate the Clinical Efficacy and Safety of Shp640 Pvp-Iodine 0.6 and Dexamethasone 0.1 Ophthalmic Suspension Compared To Placebo in the Treatment of Bacterial Conjunctivitis · 2019 | Their institution | $2,075 |
| ABBVIE INC. · 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (Durysta) · 2024 | Their institution | $2,040 |
| Glaukos Corporation · Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream 4, 6 and 8 Bid for the Treatment of Signs and Symptoms of Dry Eye Disease · 2021 | Their institution | $1,823 |
| Glaukos Corporation · Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream 4, 6 and 8 Bid for the Treatment of Presbyopia · 2021 | Their institution | $1,798 |
| ABBVIE INC. · 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (Durysta) · 2022 | Their institution | $1,681 |
| Glaukos Corporation · A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction With Cataract Surgery · 2019 | Their institution | $1,502 |
| Glaukos Corporation · Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream 4%, 6% and 8% Bid for the Treatment of Signs and Symptoms of Dry Eye Disease · 2023 | Their institution | $1,500 |
| Sight Sciences, Inc. · A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (Poag) and Cataract (Helix) · 2025 | This clinician | $1,500 |
| Glaukos Corporation · Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream 4%, 6% and 8% Bid for the Treatment of Presbyopia · 2023 | Their institution | $1,500 |
| Allergan, Inc. · Efficacy and Safety of Bimatoprost Sustained-Release (Sr) in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2020 | Their institution | $1,425 |
| Shire North American Group Inc · A Phase 3, Multi-Center, Randomized, Double-Masked Study To Evaluate the Clinical Efficacy and Safety of Shp640 Pvp-Iodine 0.6 and Dexamethasone 0.1 Ophthalmic Suspension Compared To Pvp-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis · 2019 | Their institution | $1,371 |
| Glaukos Corporation · Multicenter Investigation of Trabecular Micro-Bypass Stents Vs. Laser Trabeculoplasty · 2021 | Their institution | $1,250 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5% · 2024 | Their institution | $1,074 |
| TOPCON CORPORATION · Triton Oct A Software Pre-Study and Software Evaluation Study · 2019 | This clinician | $1,000 |
| Ocular Therapeutix, Inc. · A Prospective, Multi-Center, Randomized, Parallel-Group, Controlled Study To Evaluate the Efficacy and Safety of Otx-Tic (Travoprost) Intracameral Implant in Subjects With Open-Angle Glaucoma (Oag) Or Ocular Hypertension (Oht) · 2025 | This clinician | $1,000 |
| Novartis Pharmaceuticals Corporation · A Randomized, Double-Masked, Multicenter Study To Evaluate the Safety and Efficacy of Ecf843 Vs Vehicle in Subjects With Dry Eye Disease · 2020 | Their institution | $972 |
| Takeda Pharmaceuticals U.S.A., Inc. · A Phase 3, Multi-Center, Randomized, Double-Masked Study To Evaluate the Clinical Efficacy and Safety of Shp640 (Pvp-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared To Pvp-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis · 2020 | Their institution | $612 |
| ABBVIE INC. · 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (Durysta) (Argos) · 2023 | Their institution | $609 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5% · 2025 | Their institution | $513 |
| ABBVIE INC. · Long-Term Safety and Efficacy Extension Trial of Bimatoprost Sr · 2022 | Their institution | $360 |
| Ocular Therapeutix, Inc. · A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3a Study Evaluating the Safety and Efficacy of Otx-Tp in the Treatment of Subjects With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $350 |
| Allergan, Inc. · A Comparison of Bimatoprost Sr To Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2021 | Their institution | $304 |
| Glaukos Corporation · Prospective, Randomized Phase 3 Study Comparing Two Models of A Travoprost Intraocular Implant To Timolol Maleate Ophthalmic Solution, Usp, 0.5 · 2019 | This clinician | $265 |
| Allergan, Inc. · A Multicenter, Single-Masked, Randomized Study To Compare the Safety and Efficacy of Two Novel Artificial Tear Formulations With Systane Unit Dose for 3 Months Multicenter, Single-Masked, Randomized Study To Compare the Safety and Efficacy of Two Novel Artificial Tear Formulations With Systane Unit Dose for 3 Months in Subjects With Dry Eye Disease · 2021 | Their institution | $117 |
| Allergan, Inc. · A Comparison of Bimatoprost Sr To Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $93 |
| Glaukos Corporation · A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction With Cataract Surgery · 2020 | Their institution | $79 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1639160112
- Licence
- CA G73984California G73984: Current · expires 2028-05-31
- Trained
- Hahneman Medical College of the Pacific, 1984 · 42 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA G73984
- Taxonomy
- Federal specialty code 207WX0009X (207WX0009X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 104 Lynch Creek Way, Suite 15, Petaluma, CA, 94954
- NPI first listed
- 2005-11-02
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.